Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-05-10
2005-05-10
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S266200, C514S266230, C514S266210, C544S116000, C544S238000, C544S283000, C544S284000
Reexamination Certificate
active
06890924
ABSTRACT:
The invention relates to compounds of the formula 1and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R1, R3, R4, R5, R11, m and p are as defined herein. The invention also relates to methods of treating abnormal cell growth in mammals by administering the compounds of formula 1 and to pharmaceutical compositions for treating such disorders which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.
REFERENCES:
patent: 6225318 (2001-05-01), Sobolov-Jaynes
patent: 6284764 (2001-09-01), Kath et al.
patent: 6465449 (2002-10-01), Kath et al.
patent: 9615118 (1996-05-01), None
patent: 9730034 (1997-08-01), None
patent: 9935132 (1999-07-01), None
patent: 9935146 (1999-07-01), None
patent: 0021955 (2000-04-01), None
Vincent, et al.: Anticancer efficacy of the irreversible EGFr tyosine kinase inhibitor PD 0169414 against human tumor xenografts; Cancer Chemother Pharmacol; 45:231-238 (2000).
Showalter, et al.; Tyrosine Kinase Inhibitors: J. Med. Chem.; 42:5464-5474 (1999).
Hennequin, et al.; Design and Structure—Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitors; J. Med. Chem.; 42:5369-5389 (1999).
Wedge, et al.; ZD4190: An Orally Active Inhibitor of Vascular Endothelial Growth Factor Signaling with Broad-Spectrum Antitumor Efficacy; Cancer Research; 60:970-975 (2000).
Bhattacharya Samit Kumar
Kath John Charles
Morris Joel
Ancona Pamela C.
Berch Mark L.
Butterfield Garth
Pfizer Inc
LandOfFree
Substituted bicyclic derivatives for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted bicyclic derivatives for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted bicyclic derivatives for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3458678